This activity is expired and is no longer available for CME credit.

CME

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic Retinopathy: The Importance of Early Screening, Referral, and Management

Diabetic Retinopathy: The Importance of Early Screening, Referral, and Management

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Overview

Author(s)/Faculty: Rishi P. Singh, MD; Peter K. Kaiser, MD; M. Cecilia Lansang, MD, MPH; Leann Olansky, MD
Source: Healio - Opthamology Education Lab
Type: MonographArticles/Items: 4
Release Date: 11/15/2015Expiration Date: 11/15/2016
Credit Type: CMENumber of Credits: 1.5
Cost: FreeProvider: Vindico Medical Education
Diabetic eye disease is one of the most common causes of vision loss in the United States. As the rates of diabetes increase, the number of affected patients will rise as well. Better metabolic management would reduce the risk of progressive eye disease, and there are several approved medications to manage diabetic macular edema and diabetic retinopathy that can not only stop progression, but actually result in regression of symptoms. To maximize the effect of these interventions, early diagnosis and treatment is critical. However, data indicate that patients with diabetes are not being appropriately referred for ophthalmic care. In this publication, a multidisciplinary panel discusses the importance of early diagnosis and treatment as well as strategies for improving communication between health care providers.

CME Information

page 1 of 6